Voos, Natalie
Smith, Danielle
Kaiser, Lisa
Mahoney, Martin C.
Bradizza, Clara M.
Kozlowski, Lynn T.
Benowitz, Neal L.
O’Connor, Richard J.
Goniewicz, Maciej L.
Funding for this research was provided by:
NIH NIDA (R01DA037446, DA012393)
NCI/FDA (U54CA228110)
NIH (S1ORR026437)
Article History
Received: 15 May 2019
Accepted: 25 October 2019
First Online: 26 November 2019
Compliance with ethical standards
: Study procedures were approved by the Institutional Review Board at Roswell Park Comprehensive Cancer Center.
: MLG has received research grant support from Pfizer and served as a member of the advisory board of Johnson & Johnson. MCM is on the speakers bureau, has served as a consultant to, and has received research support from Pfizer. NLB is a consultant to Pfizer and Achieve Life Sciences and has been a paid expert witness in litigation against tobacco companies. Other authors have no conflicts to declare.
: Information and the views and opinions expressed in this presentation are those of the author only and do not necessarily represent the views, official policy, or position of the U.S. Department of Health and Human Services or any of its affiliated institutions or agencies.